JAMES SAPIRSTEIN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

MARIZYME, INC.

Filing Date Source Excerpt
2021-06-23 "Mr. Sapirstein is a highly regarded pharmaceutical industry executive with more than 35 years of success in building companies and leading the commercial launch of nearly two dozen prescription drugs..."

NANOVIRICIDES, INC.

Filing Date Source Excerpt
2019-10-28 Mr. Sapirstein has served over thirty years in the pharmaceutical industry and holds an MBA and B.Pharm. No indication of software or programming skills.
2020-02-19 James Sapirstein 2,729 * % 0 0 % * %

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-06